Efficacy and safety of low dose rivaroxaban in patients with coronary heart disease: a systematic review and meta-analysis.
Efficacy and safety of low dose rivaroxaban in patients with coronary heart disease: a systematic review and meta-analysis. J Thromb Thrombolysis. 2020 Nov; 50(4):913-920.